Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.
暂无分享,去创建一个
Michael B Lawrence | M. Lawrence | A. Klibanov | J. Rychak | J. Rivera-Nieves | Joshua J Rychak | Alexander L Klibanov | T. Pizarro | P. Ernst | P. Konkalmatt | Jose L. Tlaxca | José L Tlaxca | Peter B Ernst | Prasad R Konkalmatt | Talent I Shevchenko | Theresa T Pizarro | Jesús Rivera-Nieves | T. Shevchenko
[1] William R Wagner,et al. Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1 , 2003, Circulation.
[2] Sunita M. Jain,et al. Treatment of inflammatory bowel disease (IBD) , 2011, Pharmacological reports : PR.
[3] J. Sheehan,et al. Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating. , 2011, Journal of neurosurgery.
[4] Paul Rutgeerts,et al. Biological therapies for inflammatory bowel diseases. , 2009, Gastroenterology.
[5] D. Stewart,et al. Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle , 2007, Circulation research.
[6] Sanjiv Kaul,et al. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. , 2003, Ultrasound in medicine & biology.
[7] V. Torchilin. STRATEGIES AND MEANS FOR DRUG TARGETING: AN OVERVIEW , 2002 .
[8] F. Cominelli,et al. A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis1 , 2008, The Journal of Immunology.
[9] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[10] A. Sturm,et al. Current treatment of ulcerative colitis. , 2011, World journal of gastroenterology.
[11] Jeffrey C Bamber,et al. Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. , 2006, Ultrasound in medicine & biology.
[12] T. Karlsen,et al. Genome-wide association studies--a summary for the clinical gastroenterologist. , 2009, World journal of gastroenterology.
[13] C. Mackay,et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. , 1997, The American journal of pathology.
[14] V. Muzykantov,et al. Endothelial endocytic pathways: gates for vascular drug delivery. , 2004, Current vascular pharmacology.
[15] Douglas L. Miller,et al. Ultrasonic enhancement of gene transfection in murine melanoma tumors. , 1999, Ultrasound in medicine & biology.
[16] Stefaan C De Smedt,et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[17] Kenneth Hoyt,et al. A Triple‐Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor Vasculature , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[18] Nico de Jong,et al. Increasing the Endothelial Layer Permeability Through Ultrasound-Activated Microbubbles , 2010, IEEE Transactions on Biomedical Engineering.
[19] Cristina Pislaru,et al. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. , 2003, European heart journal.
[20] Fabio Cominelli,et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. , 2006, Gastroenterology.
[21] Andrew C. Chan,et al. Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.
[22] M. Asari,et al. Pathomechanism of cellular infiltration in the perivascular region of several organs in SAMP1/Yit mouse. , 2009, The Journal of veterinary medical science.
[23] Kumar Sharma,et al. Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.
[24] W. Muller. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. , 2003, Trends in immunology.
[25] S. Kitamura,et al. Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[26] Raffi Bekeredjian,et al. Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart , 2003, Circulation.
[27] Shunichi Homma,et al. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[28] F. Stuart Foster,et al. Microultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 in a Mouse Model of Tumor Angiogenesis , 2007, Molecular imaging.
[29] Manabu Kinoshita,et al. Intracellular Delivery of Bak BH3 Peptide by Microbubble-Enhanced Ultrasound , 2005, Pharmaceutical Research.
[30] P. Rutgeerts,et al. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[31] S. Targan,et al. Future biologic targets for IBD: potentials and pitfalls , 2010, Nature Reviews Gastroenterology &Hepatology.
[32] K. Ley,et al. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[33] G. Lichtenstein,et al. Integrating anti–tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives , 2001, American Journal of Gastroenterology.
[34] Isabelle Tardy,et al. BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis , 2010, Investigative radiology.
[35] Silvia Muro,et al. Advanced drug delivery systems that target the vascular endothelium. , 2006, Molecular interventions.
[36] R. Sartor. Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[37] K. Ley,et al. Leukocyte adhesion molecules in animal models of inflammatory bowel disease , 2008, Inflammatory bowel diseases.
[38] S. Rajagopalan,et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[39] R. Panaccione,et al. Review: Anti-adhesion molecule therapy for inflammatory bowel disease , 2010, Therapeutic advances in gastroenterology.
[40] V. Muzykantov,et al. Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.
[41] Alexander L. Klibanov,et al. Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.
[42] Thierry Bettinger,et al. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[43] K. Shibata,et al. Expression of immunoglobulin superfamily members on the lymphatic endothelium of inflamed human small intestine. , 1999, Microvascular research.
[44] A. V. D. van der Steen,et al. Sonoporation of endothelial cells by vibrating targeted microbubbles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[45] K. Ley,et al. scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis , 2010, Investigative radiology.
[46] Y. Wang,et al. Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC. , 2005, Lymphatic research and biology.
[47] M. Bachmann,et al. Averting inflammation by targeting the cytokine environment , 2010, Nature Reviews Drug Discovery.
[48] D. Crossman,et al. Microbubble-enhanced ultrasound for vascular gene delivery , 2000, Gene Therapy.
[49] J. Hossack,et al. Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles. , 2010, Ultrasound in medicine & biology.
[50] Jameel A Feshitan,et al. Microbubble size isolation by differential centrifugation. , 2009, Journal of colloid and interface science.
[51] P. Rutgeerts,et al. The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies , 2010, Alimentary pharmacology & therapeutics.
[52] R. Guy,et al. Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[53] F. Shanahan. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[54] R. Cohen. The pharmacoeconomics of biologic therapy for IBD , 2010, Nature Reviews Gastroenterology &Hepatology.
[55] S. Targan,et al. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial , 2006, Gut.
[56] M. Neurath,et al. Inflammatory bowel disorders: gene therapy solutions. , 2003, Current opinion in molecular therapeutics (Print).
[57] Raffi Bekeredjian,et al. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. , 2005, Ultrasound in medicine & biology.
[58] A. McHale,et al. Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. , 2008, Cancer letters.